Schedule 13D ownership disclosure

Nautilus Biotechnology, Inc.

Security class unavailable · CUSIP: 63909J108

Event date: 2021-06-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,153,911
Percent of class
17.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001628280-21-012358
Form type
SC 13D
Filer
Mallick Parag
CIK
CIK 1857948
Filed
Jun 16, 2021
Reporting period
Jun 09, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub